Wednesday, August 15, 2012

Professor Marco Ruggiero on MAF 314




Professor Marco Ruggiero and his research team at the University of Florence developed the probiotic substance MAF 314 in the past several years. MAF 314 was initially seen as a potential adjunct therapy for HIV and certain cancers. More recently it has been used in ME/CFS with some success. There are anecdotal indications that MAF 314 regulates gut ecology and attacks viruses through the natural production of GcMAF. MAF 314 is known to produce an abundance of GcMAF. MAF 314 is taken at a prescribed dosage once a day.

Several small pilot studies have been done by Dr. Paul Cheney (working in collaboration with Professor Ruggiero) and Professor Ruggiero himself. Dr. Cheney presented his one-month study of MAF 314 at the 2011 IAMECFS conference in Ottawa. Professor Ruggiero presented additional information in Padua a month later. There have been no additional published studies of MAF 314 since then.

In answer to a question in Ottawa about MAF 314, Dr. Cheney answered, "It works." For the past year, Dr. Cheney has used MAF 314 in his practice with selected patients. He is a true champion of this therapy. He follows his selected patients closely with various tests, including Nagalase and 1,25 dihydroxy vitamin D. Dr. Cheney has far and away the most clinical experience with MAF 314 and his continuing contributions in refining this treatment are available to his patients, as well as to subscribers to his research website. It is recommended that both MAF 314 and GcMAF be used under a doctor's supervision.

Dr. Derek Enlander in NYC has made his own version of a MAF-like substance called MAF 878. Anecdotal reports are that MAF 878 has a positive effect on patients with very few side effects.

MAF 314 was developed as an alternative to injectable GcMAF. Injectable GcMAF, as developed by Professor Nobuto Yamamoto, is seen as an adjunct therapy for HIV and various cancers. Small trials by Professor Yamamoto have not been expanded upon by others for unknown reasons. More recently injectable or chemical GcMAF has been used in patients with ME/CFS, primarily by Dr. Kenny De Meirleir, Dr. Paul Cheney and Dr. Derek Enlander. Dr. Enlander has indicated publicly that GcMAF is the best therapy for ME/CFS in the last ten years. Improvement has also been seen in these patient groups. There is a fine presentation by Dr. De Meirleir on GcMAF from a conference at Mt. Sinai ME/CFS center in late 2011. It can be viewed here.

I have written about MAF 314 in another post. It is my experience and the experience of others that MAF 314 strengthens the immune system - in unknown ways. Patients report feeling stronger on MAF 314 and MAF 878. The mechanism might be as simple as MAF operating as a super probiotic and stabilizing and improving the gut ecology. It seems to take some months before positive benefits are felt. It is unclear whether MAF 314 raises NK cell function, but that would certainly be an important benchmark for ME/CFS patients. This certainly might be a worthwhile study: Does GcMAF and MAF 314 have effects on NK cell functionality (LU 30)?

We in the ME/CFS community welcome this informative video interview of Professor Ruggiero and appreciate his research work in ME/CFS. His work in this field has continued with MAF 314 and expanded with significant research in other areas of ME/CFS. I will write about this soon.

This video interview with Professor Ruggiero was made by Peter Cairns in Professor Ruggiero's office in Florence earlier this year.

22 comments:

  1. my NK cell function rose to normal levels afetr 3 - 4 months of injectible GcMAF. it was once 2 but rose to 65 on last testing. i started to feel unwell recently and am awaiting new NK cell function results.

    ReplyDelete
  2. My Natural Killer Cell Function test results improved a great deal after being on GcMAF + Nexavir for 1 year.

    Pre-Gcmaf
    May 2009: Quest Labs NK Cell Function LU30 test results: 25 (ref range 8-170).
    March 2011: VIP labs NK Cell Function LU30 test results: 17 (ref range 8-170).

    Post-Gcmaf
    April 2012: after 1 yr of gcmaf + nexavir, Quest NKCF LU30: 48 (ref range 8-170).

    ReplyDelete
  3. Fascinating! And what a lovely man.

    I'm about to start on MAF 878 from Dr Enlander and this video contained some really interesting information that I didn't know.

    Thanks for covering this, Chris - and thanks to Prof. Ruggiero!

    ReplyDelete
  4. I'm a huge fan of MAF314. Obtained some from another patient.

    After 25 years of acute onset ME and very little response to drugs (apart from some immune modulators and anti-virals only) the MAF314 was a delight.

    As Prof R reports here the effect on my throat and neck glands was dramatic. Started at the end of the first week and continued off and on for a month in a less severe way.

    Then after 2-3 months I was stronger and more able to physically function than before. PEM was better. I could walk more and get outside my home more. The effects were also very good on my stomach.

    No drug has ever had this immediate and very good effect on me. Decades of trying new things left me with low expectations. Even my nails grew back on the MAF314 which is a pretty good placebo effect (...)

    Sadly, the good effects wore off a couple of months after I ran out. I'll need to learn how to make some now. Money is the problem for me.

    Thank you Chris for this interview. Thank you Professor Ruggiero.

    As a long term ME patient (from an 80's epidemic) I'm very grateful that MAF314 has been made available to us.

    ReplyDelete
    Replies
    1. AnonymousAugust 15, 2012 9:42 PM.. i may be able to help, please email me at: linda_lowther@yahoo.ca
      thanks!

      Delete
  5. There's hardly a way this gcmaf adverse side effect for small minority of me/cfs patients will not seem inconseqental, perhaps even shallow, given the serious illnesses this treatment helps, but does anyone have any idea why gcmaf causes hairloss in this small minority?
    For me, this occurred while injecting gcmaf and later while using maf878.

    ReplyDelete
  6. "Small trials by Professor Yamamoto have not been expanded upon by others for unknown reasons." Not quite - we have 3,000 people trialling GcMAF through around 100 doctors.

    Our GcMAF was kindly tested by Professor Ruggiero, without whom we could not have got started.

    It took Professor Ruggiero and his team of 10 professors, doctors and scientists with their excellent laboratory 314 attempts to make MAF314.

    Our scientists attempted it in our laboratory; and we can confirm that unless you get it from Prof Ruggiero's team, you haven't a hope. So make sure you get the genuine MAF314 article.

    David. 0044 752 844 1672

    ReplyDelete
  7. Hi, all.

    Thanks for posting this, Chris, and thanks to those who responded.

    I am very happy to read the two comments posted by the two "Anonymous" people that indicate that their NK cell function improved after GcMAF treatment. I'm happy for them, but also happy because I think it gives some insight into what's going on when ME/CFS is treated with GcMAF.

    For background, as some of you may know, I am the proponent of the GD-MCB hypothesis for ME/CFS (Glutathione Depletion-Methylation Cycle Block). As part of this hypothesis, I suggested in 2007 that the low NK cell function in ME/CFS, associated with low perforin, is caused by glutathione depletion in the NK cells, and that it acts at the stage of protein synthesis. If this is true, one would expect to see elevated gene expression of the perforin gene, while the level of the perforin protein itself would be low. Recent work by the Bond University group in Australia has confirmed this.

    So again, if this is true, and the GcMAF treatment raises the NK cell function, it must mean that this treatment has caused the glutathione level in these cells to rise.

    How would that happen? I suggest that the GcMAF treatment, by activating the macrophages, has knocked down the populations of intracellular pathogens, including viruses, which are known to produce nagalase, which in turn has been found to decrease after GcMAF treatment. A decrease in pathogen population would be expected to lower the inflammatory response of the immune system against the pathogens. A major component of this inflammation is the production of reactive oxygen species by cells of the immune system, raising oxidative stress and placing a demand on glutathione as the basis of the antioxidant system. So a lowering of the inflammation should allow glutathione to rise, at least to some degree.

    All of this seems consistent with what would be expected if the GD-MCB hypothesis is indeed valid. Hence, my happiness!

    Best regards,

    Rich

    ReplyDelete
  8. Interesting article and comments. I'm coming at this from the glutathione side of treatment. I've been having glutathione IVs since last fall and also changed up my diet to include many different types of probiotics. I've seen quite a bit of improvement but I haven't been sure if it was the diet+IVs or just the fact that I'm in year two of the illness when they is typically an upswing in functionality (according to Dr. Bell). It would be interesting to see what would happen if I had access to GcMAF or the super probiotics as well.

    ReplyDelete
  9. Can anyone tell me how a patient or a doctor in southwest USA can get specific information on MAF 314 or 878?

    Thank you.

    ReplyDelete
  10. How do any of us obtain access to MAF314/878 treatment?

    ReplyDelete
    Replies
    1. You can purchase MAF 878 on ebay.com

      Delete
    2. About MAF 314 you can contact here:

      Vienna
      Tel.: 01 / 40 666 00 - 15
      FAX: 01 / 40 666 00 - 14
      Mobil: 0664 / 28 29 909
      info@santos-koenig.at

      Delete
  11. I posted that my NK cell function rose to 65 following 3 months of GcMAF. I neglected to mention that I was also on Tenofovir - an HIV drug I began taking when the XMRV story came out. I didn't think the Tenofovir was important but I stopped it...and a month later, declined all the way again, despite continuing GcMAF. new and more aggressive symptoms have emerged. my bloodwork showed deficient 25-D, deficient iron, lower Cd4 count, high B cells, low kidney function, and NK cell function has dropped to 6. I have resumed Tenofovir.

    ReplyDelete
  12. Hi,

    I am HIV positive taking no antiretrovial drugs. I have been taking MAF 314 since June and i saw my NK cells raising from 300 to 411, just in a month!

    ReplyDelete
  13. Where can I buy MAF 314. Ann

    ReplyDelete
  14. The idea that this guy presents in the video is fascinating, with a little twist. He has not published anything. He mentions that he has 4 papers (yes, ONLY 4) and the latest paper where he talks about breast cancer cells is really poorly written. He uses GcMAF in the article but not the yogurt like stuff that he talks in this video (Plus, to his credit, the system used in the paper is some cell line so it is not feasible as well). Being a scientist myself, usual procedure is you publish your work before handing out to the general population. I have not seen this guy doing it. He claims, he did it but where is the paper?

    I am not being critical or trying to undermine his work. All I want to say is, if this thing works then setting up a clinical trial would be a piece of cake. Run a trial for 6 months and get paper out right away. Meanwhile, get a patent and make money. Everyone is happy. The patient gets the material that is tested and proved to be working, the pioneer makes money. Win Win situation.

    I started searching this for my son who is on Autism spectrum but after noting the points mentioned above, I am not so sure, I will give this thing a try.
    At least, if he tells me what bacterial strains are in the mixture that he uses, I may consider it. (I am not going to spend time building my own stuff because as this blog owner, I am advocating my son more than research nowadays.)

    ReplyDelete
    Replies
    1. Hi Noel, I too started looking at GcMaf for my son on the Autistic spectrum. I went to a meeting last night (26th September 2014) to hear more. Have you found out any more about this treatment? From what they were claiming at the meeting last night that they can cure Autism 100% in their clinics, yet treatment at home would produce a 25% chance of cure. Treatment would cost 6,000 Euros per week for 3 weeks in clinic. I love my son and would pay the world for him to no longer suffer the adverse effects of Autism but am so scared of falling for something that isn't proven. How are you getting on a year down the line and did you look further in to GcMaf? Kind regards, Ann.

      Delete
  15. I have the instructions for preparing MAF 314, but where to obtain the "starters" has been inexplicably omitted. The preparation of the yogurt cannot be done without these ingredients. Where do we find them?

    ReplyDelete
  16. I am starting Chemo for recuurrent Colon cancer and am seriously considering giving MAF 314 a shot after I get going with the Chemo. I believe all you need can be found to start making the culture is here:
    http://www.gcmaf.eu/gcmaf-products/bravo-probiotic/

    ReplyDelete
  17. By the way I am in no way affiliated with this company, I'm just weighing all my options.
    Benfischer66@gmail.com

    ReplyDelete
  18. http://retractionwatch.com/2014/07/25/paper-about-widely-touted-but-unapproved-cure-for-cancer-autism-retracted/

    http://scholarlyoa.com/2014/07/24/would-you-take-a-cancer-cure-proven-effective-in-a-predatory-journal/

    http://retractionwatch.com/2014/08/21/second-study-of-widely-touted-cancer-and-hiv-cure-retracted/

    ReplyDelete